findmyKOL

Nicole Lemanski, MD

Basic profile

GE Global Research

ORCID↗NPI↗
✓ Full record
RegionNiskayuna, NY · NortheastSpecialtyOphthalmologyFocusOphthalmology
Active KOLfindmyKOL type: RegionalLatest publication2026Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Nicole Lemanski is an Ophthalmology physician affiliated with GE Global Research. OpenAlex indexes 20 publications with 239 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
20publications

Distinct works indexed by OpenAlex, matched via ORCID.

239citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    40.9%
    Prostaglandin Analog14.4%
    Latanoprost50%Lumigan34%Tafluprost8%Travoprost8%
    Part D<11 patients
    Corticosteroid12.2%
    Prednisolone Acetate100%
    Part D≥84 patients

    + 3 more classes in this area

  • Anti-infectives

    37.6%
    Fluoroquinolone Antibacterial16.1%
    Moxifloxacin100%
    Part D≥84 patients
    Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor8.1%
    Valacyclovir100%
    Part D≥46 patients

    + 5 more classes in this area

  • Cancer & immunology

    13.3%
    Calcineurin inhibitor13.3%
    Restasis52%Cyclosporine38%Cequa10%
    Part D<11 patients
Where care is delivered (Part B)3% facility · 97% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”